ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in ENDRA Life Sciences Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −6 vs. Q2 2024
- Shares held
- 168.8K
- −661.3K (−79.7%) vs. Q2 2024
- Total value
- $32.9K
- −$47.7K (−59.1%) vs. Q2 2024
- New holders
- 5
- 0 more added
- Sold out
- 11
- 6 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 80,516 | $16.0K | 0.00% | +80,516 | New |
| Two Sigma Securities, LLC | 19,211 | $3.86K | 0.00% | +19,211 | New |
| Tower Research Capital LLC (TRC) | 16,326 | $3.28K | 0.00% | −17,694−52.0% | Reduced |
| Two Sigma Investments, LP | 14,175 | $2.85K | 0.00% | +14,175 | New |
| Jane Street Group, LLC | 11,213 | $2.25K | 0.00% | −105,701−90.4% | Reduced |
| Jump Financial, LLC | 10,197 | $2.05K | 0.00% | +10,197 | New |
| HRT Financial LP | 13,848 | $2.00K | 0.00% | −315,723−95.8% | Reduced |
| Morgan Stanley | 2,615 | $526 | 0.00% | −7,717−74.7% | Reduced |
| GWM Advisors LLC | 691 | $113 | 0.00% | −29,294−97.7% | Reduced |
| Bank of America Corp | 11 | $2 | 0.00% | −58−84.1% | Reduced |
| Danske Bank A/S | 3 | $1 | 0.00% | +3 | New |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −76,171−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −55,453−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −39,812−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −37,838−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −16,766−100.0% | Sold out |
| Sassicaia Capital Advisers LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −15,991−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,853−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −12,800−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |